ADVANCED PROTEOME THERAP. Aktie - Unternehmensdaten & Kurse - CA0076282098 | MoneyPeak

ADVANCED PROTEOME THERAP.

Share · CA0076282098 · A2PJ6N (XTSX)

No Price

n/a

Company Profile for ADVANCED PROTEOME THERAP. Share

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.

AI Analysis of ADVANCED PROTEOME THERAP.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of ADVANCED PROTEOME THERAP.

No AI threads available for this company yet.

Company Data

Name ADVANCED PROTEOME THERAP.

Company Advanced Proteome Therapeutics Corporation

Website https://www.advancedproteome.com

Primary Exchange

TSX-V

WKN A2PJ6N

ISIN CA0076282098

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Benjamin Krantz

Country Canada

Currency EUR

Employees -

Address 8337 Eastlake Drive, V5A 4W2 Burnaby

IPO Date 2009-07-10

Ticker Symbols

Name	Symbol
Over The Counter	APTCF

More Shares

Investors who hold ADVANCED PROTEOME THERAP. also have the following shares in their portfolio:

MITSUBISHI CORP. CDR O.N. Share

Shanghai Eliansy Industry Group Corporation Limited Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026